Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nathan J. Verlinden, PharmD"'
Autor:
Elizabeth Posney, PharmD, Chelsea Barry, PharmD, Nathan J. Verlinden, PharmD, Tara Veasey, PharmD
Publikováno v:
JHLT Open, Vol 4, Iss , Pp 100048- (2024)
Antifungal prophylaxis postheart transplant (HT) may include voriconazole or clotrimazole, which interact with tacrolimus. There is no guidance for tacrolimus adjustment when transitioning from voriconazole to clotrimazole; therefore, this study eval
Externí odkaz:
https://doaj.org/article/f98fee3faae74f59851c42ac81a7deee
Autor:
Margaret M. Buck PharmD, Chelsea I. Barry PharmD, Courtney A. Montepara PharmD, Nathan J. Verlinden PharmD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)
Cangrelor is a rapid-acting, intravenous P2Y12 inhibitor that can be used in patients after percutaneous coronary intervention who require mechanical circulatory support or as a bridge to procedure. We retrospectively reviewed adult patients who rece
Externí odkaz:
https://doaj.org/article/0d87545b3e564976b6d2cdeb2d3cd56a